SARS CoV 2 Infection Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +152 more
2022-03-29
Mar 29, 2022
M
Active, not recruiting
  • SARS-CoV-2 Infection
  • Intramuscular injection
  • Intramuscular vaccine
  • Birmingham, Alabama
  • +90 more
2022-04-04
Apr 4, 2022
C
Recruiting
  • SARS-CoV-2 Infection
  • +2 more
  • Moderna mRNA-1273
  • +2 more
  • Gaborone, Botswana
  • +53 more
2022-03-25
Mar 25, 2022
H
Active, not recruiting
  • COVID-19
  • Sars-CoV-2 Infection
  • CoronaVac
  • Turkovac
  • Ankara, Turkey
  • +3 more
2022-04-04
Apr 4, 2022
B
Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Grafton, Auckland, New Zealand
  • +11 more
2022-03-25
Mar 25, 2022
S
Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01C
  • +3 more
  • (no location specified)
2022-04-01
Apr 1, 2022
S
Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01E
  • +3 more
  • (no location specified)
2022-04-01
Apr 1, 2022
T
Active, not recruiting
  • SARS-CoV-2 Infection
  • Acute Kidney Injury
  • Placebo
  • Nicotinamide riboside
  • New York, New York
  • +3 more
2022-03-21
Mar 21, 2022
S
Not yet recruiting
  • SARS-CoV-2 Infection
  • Charlotte, North Carolina
    Onsite Clinical Solutions
2022-03-30
Mar 30, 2022
H
Recruiting
  • COVID-19
  • Sars-CoV-2 Infection
  • TURKOVAC
  • CoronaVac
  • Adana, Turkey
  • +13 more
2022-03-30
Mar 30, 2022
V
Not yet recruiting
  • SARS-CoV-2 Infection
  • VLA2001
  • Active Comparator
  • (no location specified)
2022-03-17
Mar 17, 2022
B
Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b1
  • +3 more
  • Athens, Alabama
  • +165 more
2022-03-25
Mar 25, 2022
M
Active, not recruiting
  • SARS-CoV-2 Infection
  • MT-2766 High dose
  • +2 more
  • Osaka-shi, Osaka, Japan
  • +2 more
2022-03-25
Mar 25, 2022
I
Recruiting
  • Covid19
  • SARS-CoV-2 Infection
  • 1x10^9 vp AZD1222
  • +2 more
  • London, United Kingdom
    Imperial College London
2022-03-11
Mar 11, 2022
P
Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
2022-03-23
Mar 23, 2022
U
Completed
  • COVID
  • +3 more
  • Dipyridamole 100 Milligram(mg)
  • Placebo oral tablet
  • Ann Arbor, Michigan
    University of Michigan
2022-03-18
Mar 18, 2022
B
Terminated
  • SARS-CoV-2 Infection
  • Cooperstown, New York
    Bassett Medical Center
2022-03-09
Mar 9, 2022
C
Completed
  • SARS-CoV-2 Infection
  • lung ventilation/perfusion scintigraphy
  • Monaco, Monaco
    Centre Hospitalier Princesse Grace
2022-03-08
Mar 8, 2022
L
Recruiting
  • COVID-19
  • +8 more
  • No intervention
  • Québec, Canada
    Université Laval
2022-03-08
Mar 8, 2022
P
Recruiting
  • SARS-CoV-2 Infection
  • nasal spray
  • Aix-en-Provence, France
    Dr Bouvier's Office
2022-03-14
Mar 14, 2022
E
Recruiting
  • Coronavirus
  • +2 more
  • LD Vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health (Unisante)
2022-03-21
Mar 21, 2022
L
Not yet recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • (no location specified)
2022-03-21
Mar 21, 2022
U
Active, not recruiting
  • Covid19
  • +2 more
  • Saline
  • +5 more
  • Chapel Hill, North Carolina
    General and Oral Health Center
2022-03-04
Mar 4, 2022
H
Recruiting
  • SARS-CoV-2 Infection
  • Kidney Transplant Infection
    • São Paulo, Aão Paulo, Brazil
      Hospital do Rim
    2022-03-17
    Mar 17, 2022